Iseganan hydrochloride

N/A

Report date: 2025/01/16 10:57:59
NME

Base Information

Drug NameIseganan hydrochloride
Drug Alias Nameisegananum依色加南iseganan艾塞加南IB-367-03 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsRadiation InjuriesHead and Neck NeoplasmsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRadiation InjuriesHead and Neck NeoplasmsPneumonia

Other Information

ATC CodeN/A
Related LinksKEGG